News

rss-alt RSS Feed

Showing items 1 through 10 of 18 articles.

  • WVU researchers pursue blood test for colorectal cancer

    WVU researchers pursue blood test for colorectal cancer

    Researchers at the West Virginia University Cancer Institute are evaluating a first-of-its-kind blood test for detecting colorectal cancer. Their findings may help propel the test toward inclusion in the U.S. Preventive Services Task Force’s recommendations for colorectal cancer screening.  

    Read More

  • WVU oncologist researches new treatment for cervical and vaginal cancers

    WVU oncologist researches new treatment for cervical and vaginal cancers

    Cervical cancer can be insidious. Changes to the cervix are often detected with a pap smear, but for those with limited access to health care, cervical and vaginal cancers can go unnoticed for years—silently growing, spreading and invading other organs—and by the time they’re detected, they may be so advanced that the patient’s prognosis is poor and her treatment options few. 

    Read More

  • WVU oncologist researches new treatment for cervical and vaginal cancers

    Cervical cancer can be insidious. Changes to the cervix are often detected with a pap smear, but for those with limited access to health care, cervical and vaginal cancers can go unnoticed for years—silently growing, spreading and invading other organs—and by the time they’re detected, they may be so advanced that the patient’s prognosis is poor and her treatment options few. Valerie Galvan Turner, a gynecologic oncologist at the West Virginia University Cancer Institute, has opened a randomized clinical trial to assess whether a novel supplemental treatment can help chemotherapy and radiation fight these dangerous forms of cancer better.

    Read More

  • WVU Cancer Institute participating in ovarian cancer clinical trial

    WVU Cancer Institute participating in ovarian cancer clinical trial

    The WVU Cancer Institute is enrolling patients in an innovative clinical trial to treat ovarian cancer.  

    Read More

  • WVU Cancer Institute participating in gynecologic cancer clinical trial

    WVU Cancer Institute participating in gynecologic cancer clinical trial

    The WVU Cancer Institute is enrolling patients in an innovative clinical trial to treat uterine and vaginal cancer. 

    Read More

  • Patrick Ma lab presents research at ASCO meeting, Xiaoliang Wu wins Merit Award

    Patrick Ma lab presents research at ASCO meeting, Xiaoliang Wu wins Merit Award

    Patrick Ma, M.D., co-leader of the WVU Cancer Institute Sara Crile Allen & James Frederick Allen Comprehensive Lung Cancer Program and director of the Clinical Lung Cancer Program, and Xiaoliang Wu, M.D., Ph.D., postdoctoral research fellow in Dr. Ma’s lab, were featured presenters at the 2018 American Society of Clinical Oncology (ASCO) Annual Scientific Meeting this June.

    Read More

  • Cancer Institute seeks nominations for annual employee recognition awards

    Cancer Institute seeks nominations for annual employee recognition awards

    The WVU Cancer Institute Employee Recognition Awards Committee is now accepting nominations for its annual Employee Recognition Awards Program.

    Read More

  • Clinical Trial Data: Good Documentation Practices

    WVCTSI will begin a new four-part Clinical and Translational Research Seminar Series focusing on clinical trials. During the first installment in this new series, Tanya Moran, MS, WVCTSI senior quality assurance and auditing manager, and Shelley Welch, RN, MSHS, CCRC, WVCTSI clinical research services manager, will present “Clinical Trial Data: Good Documentation Practices.”

    Read More

  • WVU Cancer Institute participates in groundbreaking study on new cancer drug

    WVU Cancer Institute participates in groundbreaking study on new cancer drug

    The WVU Cancer Institute is one of several sites nationwide that participated in a groundbreaking clinical research study of a novel drug proven very effective in the treatment of pediatric and adult cancers that carry a specific genetic mutation.

    Read More

  • WVU Clinical Trials Research Unit among top ten nationally for clinical trials accrual

    WVU Clinical Trials Research Unit among top ten nationally for clinical trials accrual

    Congratulations to the WVU Clinical trials Research Unit (CTRU) and Dr. Adham Salkeni, WVU’s principal investigator for the NRG Oncology group, the largest clinical trials collaborative network in the United States.  During the recent biannual meeting of the NRG, our CTRU was recognized as among the top ten main member sites to enroll the most patients on cancer clinical trials between January and June 2017.  “This places WVU on the national map for clinical trials accrual,” Salkeni said.  “This shows that we offer state-of-the-art research studies that examine the role of targeted therapies for the treatment of a wide variety of cancers that affect our patient population.”

    Read More